Esperovax, a leading developer of oral mRNA biologics, and Life Magnetics, Inc., creators of RNA stabilization technology, today announced the signing of an agreement to co-develop an innovative new oral RNA therapeutic delivery system for colorectal cancer patients that can be stored at room temperature.
Oral and room temperature delivery of RNA therapeutics is a holy grail for the pharmaceutical industry. RNA therapeutics are safer, easier to design, and have far more targets than small molecule drugs. To date, the major limitation of RNA therapeutics is product shelf life. For example, the lifetime of mRNA is only around 7 hours at room temperature.
